Holen Sie sich die Stockscreener-App
3.73
1.91%
0.07
Handel nachbörslich:
3.80
0.07
+1.88%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt MNKD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.66
Offen:
$3.71
24-Stunden-Volumen:
2.69M
Relative Volume:
0.94
Marktkapitalisierung:
$1.14B
Einnahmen:
$248.37M
Nettoeinkommen (Verlust:
$11.74M
KGV:
74.60
EPS:
0.05
Netto-Cashflow:
$18.24M
1W Leistung:
+7.65%
1M Leistung:
-1.06%
6M Leistung:
-32.79%
1J Leistung:
-26.43%
1-Tages-Spanne:
$3.67
$3.81
1-Wochen-Bereich:
$3.3812
$3.81
52-Wochen-Spanne:
$3.3812
$7.63
Mannkind Corp Stock (MNKD) Company Profile
Firmenname
Mannkind Corp
Sektor
Branche
Telefon
818-661-5000
Adresse
1 CASPER STREET, DANBURY, CA
Vergleichen Sie MNKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MNKD
Mannkind Corp
|
3.73 | 1.05B | 248.37M | 11.74M | 18.24M | 0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Mannkind Corp Stock (MNKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-16 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-02-10 | Eingeleitet | Wedbush | Outperform |
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-12-19 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2023-10-10 | Eingeleitet | Wedbush | Outperform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-24 | Eingeleitet | Oppenheimer | Outperform |
| 2019-10-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-05-14 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
| 2018-02-28 | Herabstufung | Maxim Group | Hold → Sell |
| 2017-11-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2017-10-10 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-10-06 | Bestätigt | Maxim Group | Buy |
| 2017-08-11 | Eingeleitet | Maxim Group | Buy |
| 2016-05-10 | Bestätigt | Piper Jaffray | Underweight |
| 2016-05-10 | Bestätigt | RBC Capital Mkts | Underperform |
| 2016-01-06 | Bestätigt | Piper Jaffray | Underweight |
| 2016-01-06 | Bestätigt | RBC Capital Mkts | Underperform |
| 2015-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Underperform |
| 2015-09-09 | Herabstufung | Piper Jaffray | Neutral → Underweight |
| 2015-08-03 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-05-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2015-05-11 | Bestätigt | MLV & Co | Hold |
| 2015-04-16 | Bestätigt | RBC Capital Mkts | Outperform |
Alle ansehen
Mannkind Corp Aktie (MNKD) Neueste Nachrichten
ISCG's Underlying Holdings Predict 18% Gain Potential - AInvest
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement - WebWire
MannKind Corporation (NASDAQ:MNKD) Q2 2025 Earnings Call Transcript - Insider Monkey
MannKind Corporation: A Post-Q2 2025 Deep Dive — Is This the Catalyst-Driven Turnaround Play Investors Have Been Waiting For? - AInvest
MannKind And Blackstone Announce Up To $500 Mln Strategic Financing Agreement - Nasdaq
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update - GlobeNewswire
MannKind shares tumble as revenue misses expectations By Investing.com - Investing.com South Africa
MannKind shares tumble as revenue misses expectations - Investing.com
Earnings call transcript: MannKind Q2 2025 results see mixed market reaction - Investing.com India
MannKind (MNKD) Q2 Revenue Rises 6% - The Motley Fool
MannKind (MNKD) Secures $500 Million Strategic Financing from Bl - GuruFocus
MannKind Corp stock hits 52-week low at 3.5 USD By Investing.com - Investing.com Australia
MannKind Corp stock hits 52-week low at 3.5 USD - Investing.com India
MannKind Corp reports results for the quarter ended June 30Earnings Summary - TradingView
MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
MannKind Announces $500M Financing Agreement With Blackstone After Q2 Revenue Miss: Retail Believes Stock Is ‘Ridiculously Undervalued’ - Stocktwits
MannKind (MNKD) Reports Break-Even Earnings for Q2 - Yahoo Finance
MannKind secures up to $500 million strategic financing from Blackstone - Investing.com
MannKind Corporation Secures Up to $500 Million Strategic Financing Agreement with Blackstone - Quiver Quantitative
MannKind Corporation Reports Second Quarter 2025 Financial Results - TradingView
MannKind Secures Massive $500M Blackstone Backing: $75M Immediate Funding for Inhaled Therapeutics Growth - Stock Titan
Wedbush Maintains a Buy on MannKind Corporation (MNKD) - Insider Monkey
10 Best Strong Buy Penny Stocks to Buy Now - Insider Monkey
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of MannKind Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 15, 2016MNKD - ACCESS Newswire
H.C. Wainwright Affirms MannKind Corp (MNKD)’s ‘Buy’ Rating Buoyed by Product Pipeline - Insider Monkey
MannKind Corporation Receives 'Buy' Rating from H.C. Wainwright Amid Strong Growth and Promising Product Pipeline - AInvest
Wedbush Remains Bullish on MannKind Corporation (MNKD) - Insider Monkey
14 Best Biotech Penny Stocks to Buy Right Now - Insider Monkey
10 Penny Stocks That Will Skyrocket - Insider Monkey
MannKind Corporation to Release Second Quarter 2025 Financial Results and Host Webcast on August 6, 2025 - Quiver Quantitative
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025 - GlobeNewswire
What makes MannKind Corporation stock price move sharplyMomentum Based Equity Trading Plans Reviewed - metal.it
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
AI Tools Suggest MannKind Corporation May Outperform This WeekChart Driven High Reward Trading Setup Presented - metal.it
Why is MannKind Corporation stock attracting strong analyst attentionFree Daily Trading Room Entry - Jammu Links News
How volatile is MannKind Corporation stock compared to the marketCapitalize on fast-moving stock opportunities - Jammu Links News
RBC Capital Lowered the PT on MannKind Corporation (MNKD), Kept a Buy Rating - Insider Monkey
How MannKind Corporation stock performs during market volatilityCapital Safe Smart Trades - metal.it
7 High Growth Penny Stocks That Are Profitable in 2025 - Insider Monkey
What drives MannKind Corporation stock priceFree Stock Selection - PrintWeekIndia
MannKind stock price target lowered to $8 at RBC Capital on model updates - Investing.com Canada
MannKind Corporation (MNKD) Presented Inhaled Insulin Therapy At American Diabetes Association - Insider Monkey
What analysts say about MannKind Corporation stockLightning-fast capital gains - jammulinksnews.com
11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey
MannKind Corporation Stock Analysis and ForecastBreakthrough profits - jammulinksnews.com
MannKind (NASDAQ:MNKD) Upgraded at HC Wainwright - Defense World
Finanzdaten der Mannkind Corp-Aktie (MNKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Mannkind Corp-Aktie (MNKD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thomson David | EVP Genl Counsel & Secretary |
Jul 16 '25 |
Sale |
3.94 |
7,466 |
29,416 |
841,719 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):